In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

NCT06246630 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Pancreatic Neuroendocrine Tumor

Interventions

OTHER: Chemotherapy and targeted-therapy guided by organoid drug sensitivity test

Sponsor

Ruijin Hospital

Collaborators

[object Object]